CSPC PHARMACEUTGR Book Value Per Share vs. Market Capitalization

CVGU Stock  EUR 2.30  0.02  0.88%   
Considering CSPC PHARMACEUTGR's profitability and operating efficiency indicators, CSPC PHARMACEUTGR ADR4 may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess CSPC PHARMACEUTGR's ability to earn profits and add value for shareholders.
For CSPC PHARMACEUTGR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CSPC PHARMACEUTGR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CSPC PHARMACEUTGR ADR4 utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CSPC PHARMACEUTGR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CSPC PHARMACEUTGR ADR4 over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between CSPC PHARMACEUTGR's value and its price as these two are different measures arrived at by different means. Investors typically determine if CSPC PHARMACEUTGR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CSPC PHARMACEUTGR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CSPC PHARMACEUTGR ADR4 Market Capitalization vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CSPC PHARMACEUTGR's current stock value. Our valuation model uses many indicators to compare CSPC PHARMACEUTGR value to that of its competitors to determine the firm's financial worth.
CSPC PHARMACEUTGR ADR4 is rated third in book value per share category among its peers. It is rated fourth in market capitalization category among its peers creating about  1,360,224,938  of Market Capitalization per Book Value Per Share. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSPC PHARMACEUTGR's earnings, one of the primary drivers of an investment's value.

CSPC Market Capitalization vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

CSPC PHARMACEUTGR

Book Value per Share

 = 

Common Equity

Average Shares

 = 
9.41 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

CSPC PHARMACEUTGR

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
12.8 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

CSPC Market Capitalization vs Competition

CSPC PHARMACEUTGR ADR4 is rated fourth in market capitalization category among its peers. Market capitalization of Drug Manufacturers—General industry is currently estimated at about 322.85 Billion. CSPC PHARMACEUTGR holds roughly 12.8 Billion in market capitalization claiming about 4% of equities under Drug Manufacturers—General industry.
Capitalization  Total debt  Revenue  Valuation  Workforce

CSPC PHARMACEUTGR Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CSPC PHARMACEUTGR, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CSPC PHARMACEUTGR will eventually generate negative long term returns. The profitability progress is the general direction of CSPC PHARMACEUTGR's change in net profit over the period of time. It can combine multiple indicators of CSPC PHARMACEUTGR, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. CSPC PHARMACEUT operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21527 people.

CSPC Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CSPC PHARMACEUTGR. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CSPC PHARMACEUTGR position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CSPC PHARMACEUTGR's important profitability drivers and their relationship over time.

Use CSPC PHARMACEUTGR in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CSPC PHARMACEUTGR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSPC PHARMACEUTGR will appreciate offsetting losses from the drop in the long position's value.

CSPC PHARMACEUTGR Pair Trading

CSPC PHARMACEUTGR ADR4 Pair Trading Analysis

The ability to find closely correlated positions to CSPC PHARMACEUTGR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CSPC PHARMACEUTGR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CSPC PHARMACEUTGR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CSPC PHARMACEUTGR ADR4 to buy it.
The correlation of CSPC PHARMACEUTGR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CSPC PHARMACEUTGR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CSPC PHARMACEUTGR ADR4 moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CSPC PHARMACEUTGR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CSPC PHARMACEUTGR position

In addition to having CSPC PHARMACEUTGR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Global Macro ETFs Thematic Idea Now

Global Macro ETFs
Global Macro ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in CSPC Stock

To fully project CSPC PHARMACEUTGR's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CSPC PHARMACEUTGR ADR4 at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CSPC PHARMACEUTGR's income statement, its balance sheet, and the statement of cash flows.
Potential CSPC PHARMACEUTGR investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although CSPC PHARMACEUTGR investors may work on each financial statement separately, they are all related. The changes in CSPC PHARMACEUTGR's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CSPC PHARMACEUTGR's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.